General Information of Drug Off-Target (DOT) (ID: OTME3VXN)

DOT Name Large ribosomal subunit protein uL13 (RPL13A)
Synonyms 23 kDa highly basic protein; 60S ribosomal protein L13a
Gene Name RPL13A
Related Disease
Cerebral infarction ( )
Neoplasm ( )
Cataract ( )
Lung adenocarcinoma ( )
Non-small-cell lung cancer ( )
Uveal Melanoma ( )
Meningioma ( )
UniProt ID
RL13A_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
4UG0 ; 4V6X ; 5AJ0 ; 5LKS ; 5T2C ; 6IP5 ; 6IP6 ; 6IP8 ; 6LQM ; 6LSR ; 6LSS ; 6LU8 ; 6OLE ; 6OLF ; 6OLG ; 6OLI ; 6OLZ ; 6OM0 ; 6OM7 ; 6QZP ; 6W6L ; 6XA1 ; 6Y0G ; 6Y2L ; 6Y57 ; 6Y6X ; 6Z6L ; 6Z6M ; 6Z6N ; 6ZM7 ; 6ZME ; 6ZMI ; 6ZMO ; 7BHP ; 7F5S ; 7OW7 ; 7QVP ; 7XNX ; 7XNY ; 8A3D ; 8FKP ; 8FKQ ; 8FKR ; 8FKS ; 8FKT ; 8FKU ; 8FKV ; 8FKW ; 8FKX ; 8FKY ; 8FKZ ; 8FL0 ; 8FL2 ; 8FL3 ; 8FL4 ; 8FL6 ; 8FL7 ; 8FL9 ; 8FLA ; 8FLB ; 8FLC ; 8FLD ; 8FLE ; 8FLF ; 8G5Y ; 8G5Z ; 8G60 ; 8G61 ; 8G6J ; 8GLP ; 8IDT ; 8IDY ; 8IE3 ; 8INE ; 8INF ; 8INK ; 8IPD ; 8IPX ; 8IPY ; 8IR1 ; 8IR3 ; 8JDJ ; 8JDK ; 8JDL ; 8JDM
Pfam ID
PF00572
Sequence
MAEVQVLVLDGRGHLLGRLAAIVAKQVLLGRKVVVVRCEGINISGNFYRNKLKYLAFLRK
RMNTNPSRGPYHFRAPSRIFWRTVRGMLPHKTKRGQAALDRLKVFDGIPPPYDKKKRMVV
PAALKVVRLKPTRKFAYLGRLAHEVGWKYQAVTATLEEKRKEKAKIHYRKKKQLMRLRKQ
AEKNVEKKIDKYTEVLKTHGLLV
Function
Associated with ribosomes but is not required for canonical ribosome function and has extra-ribosomal functions. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation and subsequent phosphorylation dissociates from the ribosome and assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation. In the GAIT complex interacts with m7G cap-bound eIF4G at or near the eIF3-binding site and blocks the recruitment of the 43S ribosomal complex. Involved in methylation of rRNA.
KEGG Pathway
Ribosome (hsa03010 )
Coro.virus disease - COVID-19 (hsa05171 )
Reactome Pathway
Peptide chain elongation (R-HSA-156902 )
SRP-dependent cotranslational protein targeting to membrane (R-HSA-1799339 )
Viral mRNA Translation (R-HSA-192823 )
Selenocysteine synthesis (R-HSA-2408557 )
Major pathway of rRNA processing in the nucleolus and cytosol (R-HSA-6791226 )
Formation of a pool of free 40S subunits (R-HSA-72689 )
GTP hydrolysis and joining of the 60S ribosomal subunit (R-HSA-72706 )
Eukaryotic Translation Termination (R-HSA-72764 )
Regulation of expression of SLITs and ROBOs (R-HSA-9010553 )
Response of EIF2AK4 (GCN2) to amino acid deficiency (R-HSA-9633012 )
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) (R-HSA-975956 )
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) (R-HSA-975957 )
L13a-mediated translational silencing of Ceruloplasmin expression (R-HSA-156827 )

Molecular Interaction Atlas (MIA) of This DOT

7 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Cerebral infarction DISR1WNP Definitive Biomarker [1]
Neoplasm DISZKGEW Definitive Altered Expression [2]
Cataract DISUD7SL Strong Altered Expression [3]
Lung adenocarcinoma DISD51WR Strong Biomarker [4]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [5]
Uveal Melanoma DISA7ZGL Strong Altered Expression [6]
Meningioma DISPT4TG moderate Altered Expression [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Large ribosomal subunit protein uL13 (RPL13A). [8]
TAK-243 DM4GKV2 Phase 1 TAK-243 increases the sumoylation of Large ribosomal subunit protein uL13 (RPL13A). [17]
------------------------------------------------------------------------------------
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Large ribosomal subunit protein uL13 (RPL13A). [9]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Large ribosomal subunit protein uL13 (RPL13A). [10]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Large ribosomal subunit protein uL13 (RPL13A). [11]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide decreases the expression of Large ribosomal subunit protein uL13 (RPL13A). [12]
Cannabidiol DM0659E Approved Cannabidiol increases the expression of Large ribosomal subunit protein uL13 (RPL13A). [13]
Troglitazone DM3VFPD Approved Troglitazone decreases the expression of Large ribosomal subunit protein uL13 (RPL13A). [14]
Ethanol DMDRQZU Approved Ethanol decreases the expression of Large ribosomal subunit protein uL13 (RPL13A). [15]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the mutagenesis of Large ribosomal subunit protein uL13 (RPL13A). [16]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Large ribosomal subunit protein uL13 (RPL13A). [18]
chloropicrin DMSGBQA Investigative chloropicrin affects the expression of Large ribosomal subunit protein uL13 (RPL13A). [19]
AHPN DM8G6O4 Investigative AHPN decreases the expression of Large ribosomal subunit protein uL13 (RPL13A). [20]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)

References

1 EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells.BMC Mol Biol. 2010 Aug 17;11:61. doi: 10.1186/1471-2199-11-61.
2 Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells.J Steroid Biochem Mol Biol. 2011 Jul;125(3-5):219-25. doi: 10.1016/j.jsbmb.2011.03.005. Epub 2011 Mar 21.
3 Decreased expression of ribosomal proteins in human age-related cataract.Invest Ophthalmol Vis Sci. 2002 Jan;43(1):198-204.
4 c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.Oncotarget. 2016 Oct 4;7(40):65514-65539. doi: 10.18632/oncotarget.11804.
5 Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro.Mol Med Rep. 2015 May;11(5):3767-73. doi: 10.3892/mmr.2015.3159. Epub 2015 Jan 8.
6 Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices.J Cancer Res Clin Oncol. 2010 Apr;136(4):577-86. doi: 10.1007/s00432-009-0692-3. Epub 2009 Oct 13.
7 Validation of Reference Genes for Expression Studies in Human Meningiomas under Different Experimental Settings.Mol Neurobiol. 2018 Jul;55(7):5787-5797. doi: 10.1007/s12035-017-0800-3. Epub 2017 Oct 27.
8 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
9 Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells. J Signal Transduct. 2012;2012:204236. doi: 10.1155/2012/204236. Epub 2012 Oct 9.
10 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
11 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
12 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
13 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
14 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
15 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
16 Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen. 2014 Dec;775-776:48-54. doi: 10.1016/j.mrgentox.2014.10.011. Epub 2014 Nov 4.
17 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
18 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
19 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
20 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.